- Home
- FLGC vs ERNA Comparison
FLGC vs ERNA Comparison
Compare FLGC & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- ERNA
- Stock Information
- Founded
- FLGC 2019
- ERNA 2018
- Country
- FLGC United States
- ERNA United States
- Employees
- FLGC N/A
- ERNA N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- FLGC Health Care
- ERNA Health Care
- Exchange
- FLGC Nasdaq
- ERNA Nasdaq
- Market Cap
- FLGC 17.3M
- ERNA 14.5M
- IPO Year
- FLGC 2021
- ERNA N/A
- Fundamental
- Price
- FLGC $0.59
- ERNA $0.18
- Analyst Decision
- FLGC Strong Buy
- ERNA
- Analyst Count
- FLGC 4
- ERNA 0
- Target Price
- FLGC $5.67
- ERNA N/A
- AVG Volume (30 Days)
- FLGC 117.8K
- ERNA 174.2K
- Earning Date
- FLGC 05-13-2025
- ERNA 05-13-2025
- Dividend Yield
- FLGC N/A
- ERNA N/A
- EPS Growth
- FLGC N/A
- ERNA N/A
- EPS
- FLGC N/A
- ERNA N/A
- Revenue
- FLGC $59,505,000.00
- ERNA $582,000.00
- Revenue This Year
- FLGC $4.28
- ERNA N/A
- Revenue Next Year
- FLGC N/A
- ERNA N/A
- P/E Ratio
- FLGC N/A
- ERNA N/A
- Revenue Growth
- FLGC N/A
- ERNA 755.88
- 52 Week Low
- FLGC $0.59
- ERNA $0.16
- 52 Week High
- FLGC $2.75
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- FLGC 35.15
- ERNA 29.23
- Support Level
- FLGC $0.59
- ERNA $0.16
- Resistance Level
- FLGC $0.72
- ERNA $0.26
- Average True Range (ATR)
- FLGC 0.05
- ERNA 0.03
- MACD
- FLGC 0.00
- ERNA -0.01
- Stochastic Oscillator
- FLGC 3.85
- ERNA 20.75
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.